| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.0097 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |